Support WBURFDA approves first gene-editing treatment for human illnessPlay03:58Download AudioRob SteinDecember 08, 2023 Share"I'm ecstatic. It's a blessing that they approved this therapy," said Victoria Gray, the first person in the U.S. to undergo CRISPR gene-editing for sickle cell, of the Food and Drug Administration's decision. (Orlando Gili)
